Brind.

SeaStar Medical filed a registration statement with the SEC on August 1, 2025, with H.C. Wainwright & Co. serving as the exclusive placement agent.

Steady: 1 development in the last 24 hours, 1 in the last 7 days Updated 39 minutes ago

The latest in this situation

  1. SeaStar Medical submitted a premarket approval application to the FDA and discussed trial enrollment plans.

How it started

3 reports, 1 independent, last reported Aug 1. The briefing below covers this first event.

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

SeaStar Medical filed a registration statement with the SEC on August 1, 2025, with H.C. Wainwright & Co. serving as the exclusive placement agent.

Who's involved

What this event is mainly about
Securities and Exchange Commission

How it developed

Newest first. Tap a step to see who reported it.
  1. SeaStar Medical submitted a premarket approval application to the FDA and discussed trial enrollment plans.Sub-event
  2. SeaStar Medical filed a registration statement with the SEC.1 source

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • GlobeNewswireSeaStar Medical Announces $4.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules DENVER, July 31, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU),
  • GlobeNewswireSeaStar Medical Announces $4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules DENVER, July 10, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a
  • Unknown outlet